NCT04278937View on ClinicalTrials.gov

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

February 15, 2020

Study Completion Date

April 15, 2020

Conditions
Preterm Birth
Interventions
DRUG

Azithromycin Tablets

one tablet orally twice daily for three days in 3 courses at 14 weeks, 24 weeks and 32 weeks

Trial Locations (1)

Unknown

Ain Shams Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER

NCT04278937 - Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage | Biotech Hunter | Biotech Hunter